Skip to content
AASLD Family of Websites: Liver Fellow Network
AASLD.org AASLD Foundation LiverLearning Career Center Journals The Liver Meeting HCV Guidelines
AASLD Logo
AASLD Logo

LFN Main Navigation

  • Topics
    Acute Liver Failure Alcohol-Associated Liver Disease Autoimmune Hepatitis Career Development and Mentorship Cholestatic Liver Disease Complications of Liver Disease and Portal Hypertension Drug-Induced Liver Disease HepMadness Inherited Disorders Liver Anatomy, Development, and Physiology Liver Infections Liver Physiology Liver Related Infections MASLD/MASH Neoplasms of the Liver Pathology Pediatrics Pregnancy-Related Liver Disease Symptoms and Clinical Presentation of Liver Disease and Portal HTN Systemic Conditions with Hepatic Manifestations Transplantation and Surgery Vascular Viral Hepatitis
  • Core Series
    Back to Basics Clinical Pearls Webinars Evidence Corner Pathology Pearls Podcast The Why? Series Tools of the Trade View All Core Series Practice Questions
  • Tweetorials
  • About
  • Core Series
  • Evidence Corner
  • Rise Of The Machines

Rise of The Machines

October 16, 2024

Sanad Dawod

Share

Copy Link Twitter Facebook
  1. Discarded livers tested by normothermic machine perfusion in the VITTAL trial: Secondary end points and 5-year outcomes
  2. Liver transplantation with uncontrolled versus controlled DCD donors using normothermic regional perfusion and ex-situ machine perfusion
  3. Viability assessment and transplantation of fatty liver grafts using end‐ischemic normothermic machine perfusion
  4. Can ex-situ normothermic perfusion improve graft survival compared to static cold storage among donation after circulatory death liver allografts?
  5. Development of a portable abdominal normothermic regional perfusion (A-NRP) program in the United States
HepMadness

Share

Copy Link Twitter Facebook

Written By:

Sanad Dawod

Related Content

Beans, beans, they're good for your liver-The kidney and liver's love/hate relationship

October 16, 2024

Statins: So Hot Right Now?

October 16, 2024

Living with Cirrhosis: symptom insights and innovations

October 16, 2024

AASLD LFN Logo

Follow Us

Disclaimer & Privacy Policy

© 2025 American Association for the Study of Liver Diseases